Discontinuation report RAN-LISINOPRIL

Last updated on 2020-05-27 History
Report ID 115803
Drug Identification Number 02294230
Brand name RAN-LISINOPRIL
Common or Proper name LISINOPRIL
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status DORMANT
Active Ingredient(s) LISINOPRIL
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 500
ATC code C09AA
ATC description ACE INHIBITORS, PLAIN
Reason for discontinuation Manufacturing issues
Anticipated discontinuation date
Actual discontinuation date 2020-05-08
Remaining supply date 2020-05-08
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-05-27 English Compare
v2 2020-05-27 French Compare

Showing 1 to 2 of 2